United Kingdom

Biofidelity raises €22M to expand in the US and enhance Cancer Detection Technology
Biofidelity, a Cambridge-based genomic technology company at the commercial stage, has announced a significant funding boost of $24M (approximately €22M), bringing its total funding to $60M (approximately €55.3M). This round of financing was supported by current investors, including Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures.
SolarMente, a Barcelona-based cleantech startup, has proudly announced that renowned actor and environmental activist Leonardo DiCaprio has become one of its latest investors. While the exact amount of the investment remains undisclosed, this new partnership marks a significant endorsement for the company, following a substantial €50M investment from GNE Finance

The best Articles in our Network